Baseline Characteristics of Rheumatoid Arthritis Patients Starting Certolizumab Pegol Therapy And Glucocorticoid Prescription In The Eclair Study In 2012–2013

A. Saraux (), R. Flipo, F Fagnani, I. Bru, G. Cukierman, J. Joubert, W. Czarlewski, J. Dunkel, J. Massol and Bernard Combe
Additional contact information
A. Saraux: CHU - BREST - Hôpital de la Cavale Blanche - CHRU Brest
R. Flipo: Hôpital Roger Salengro [Lille]
F Fagnani: Cemka-eval [Bourg La Reine]
I. Bru: UCB Pharma, Colombes
G. Cukierman: UCB Pharma, Colombes
J. Joubert: UCB Pharma, Colombes
W. Czarlewski: UCB Pharma, Colombes
J. Dunkel: UCB Pharma, Monheim
J. Massol: Département de Génétique et Reproduction - CHRU Besançon - Centre Hospitalier Régional Universitaire de Besançon - Hôpital Saint-Jacques
Bernard Combe: Hôpital Lapeyronie [CHU Montpellier] - CHRU Montpellier - Centre Hospitalier Régional Universitaire [Montpellier], IGMM - Institut de Génétique Moléculaire de Montpellier - UM - Université de Montpellier - CNRS - Centre National de la Recherche Scientifique

Post-Print from HAL

Date: 2015-11
References: Add references at CitEc
Citations:

Published in Value in Health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 2015, 18 (7), pp.A637. ⟨10.1016/j.jval.2015.09.2265⟩

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:hal-01901128

DOI: 10.1016/j.jval.2015.09.2265

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().